NEUROPACE, INC. Gain (Loss) on Extinguishment of Debt
NEUROPACE, INC. (NPCE) reported Gain (Loss) on Extinguishment of Debt of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:GainsLossesOnExtinguishmentOfDebt · last filed 2026-08-11
- NEUROPACE, INC. gain (loss) on extinguishment of debt for the quarter ending 2025-12-31 was $0.00.
- NEUROPACE, INC. gain (loss) on extinguishment of debt for the quarter ending 2025-09-30 was $0.00.
- NEUROPACE, INC. gain (loss) on extinguishment of debt for the quarter ending 2024-12-31 was $0.00.
- NEUROPACE, INC. gain (loss) on extinguishment of debt for the quarter ending 2024-09-30 was $0.00.
- NEUROPACE, INC. gain (loss) on extinguishment of debt for fiscal 2025 was -$527.00K.
- NEUROPACE, INC. gain (loss) on extinguishment of debt for fiscal 2024 was $0.00.
- NEUROPACE, INC. gain (loss) on extinguishment of debt for fiscal 2021 was $0.00.
- NEUROPACE, INC. gain (loss) on extinguishment of debt for fiscal 2020 was -$182.00K.
| Period end | Gain (Loss) on Extinguishment of Debt 3 month | Gain (Loss) on Extinguishment of Debt 6 month | Gain (Loss) on Extinguishment of Debt 9 month | Gain (Loss) on Extinguishment of Debt 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-11 | |||
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $0.00 derived: sum of 2 quarters · filed 2026-03-03 | -$527.00K 10-K · filed 2026-03-03 | |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | -$527.00K 10-Q · filed 2025-11-04 | ||
| 2025-06-30 | -$527.00K 10-Q · filed 2026-08-11 | |||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $0.00 derived: sum of 2 quarters · filed 2026-03-03 | $0.00 10-K · filed 2026-03-03 | |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $0.00 10-Q · filed 2025-11-04 | ||
| 2024-06-30 | $0.00 10-Q · filed 2025-08-12 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $0.00 10-K · filed 2022-03-10 | ||
| 2021-09-30 | $0.00 10-Q · filed 2021-11-10 | |||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | -$182.00K 10-K · filed 2022-03-10 | ||
| 2020-09-30 | -$182.00K 10-Q · filed 2021-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |